PapersFlow Research Brief
Ferrocene Chemistry and Applications
Research Guide
What is Ferrocene Chemistry and Applications?
Ferrocene chemistry and applications is the study of ferrocene and its derivatives in bioorganometallic contexts, focusing on synthesis, biochemical properties, molecular modeling, antiproliferative effects, chirality organization, and potential as anticancer drugs.
This field encompasses 18,241 works on ferrocene-based compounds in cancer research and medicinal chemistry. It examines their biological activity, including as estrogen receptor modulators. Key investigations cover antiproliferative effects and chirality organization of ferrocenes.
Topic Hierarchy
Research Sub-Topics
Ferrocene Derivatives as Anticancer Agents
This sub-topic examines the synthesis and biological evaluation of ferrocene-based organometallic compounds exhibiting antiproliferative activity against cancer cell lines. Researchers investigate structure-activity relationships and mechanisms of action including ROS generation and DNA damage.
Ferrocene Estrogen Receptor Modulators
This area focuses on ferrocene conjugates mimicking tamoxifen and raloxifene for selective estrogen receptor modulation in breast cancer therapy. Studies explore binding affinities, conformational dynamics, and selective estrogen receptor modulator (SERM) properties.
Chiral Ferrocene Derivatives in Bioorganometallics
Researchers develop planar chiral ferrocenes and study their stereoselective synthesis, resolution methods, and enantioselective biological interactions. This includes applications in asymmetric catalysis relevant to medicinal synthesis.
Molecular Modeling of Ferrocene Drug Candidates
This sub-topic employs computational chemistry including DFT calculations and molecular dynamics to model ferrocene-protein interactions and redox properties. It predicts binding modes and metabolic stability for rational drug design.
Ferrocene Conjugates for Targeted Drug Delivery
Studies synthesize ferrocene-peptide or ferrocene-polymer conjugates for improved bioavailability and tumor targeting. Research evaluates pharmacokinetics, cellular uptake, and synergy with existing anticancer agents.
Why It Matters
Ferrocene derivatives contribute to medicinal chemistry through organometallic anticancer compounds, as detailed in 'Organometallic Anticancer Compounds' by Gasser et al. (2010), which reviews their potential beyond traditional platinum drugs like cisplatin. This work highlights ferrocene's role in expanding metal-based therapies, with 1571 citations reflecting its influence. Applications target tumor cell death mechanisms similar to cisplatin, addressed in 'Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects' by Florea and Büsselberg (2011, 1720 citations), where platinum interference with DNA replication inspires ferrocene analogs. In cancer research, these compounds offer alternatives to agents like those in 'Platinum Compounds: a New Class of Potent Antitumour Agents' by Rosenberg et al. (1969, 3890 citations).
Reading Guide
Where to Start
'Organometallic Anticancer Compounds' by Gasser et al. (2010), as it provides a direct perspective on ferrocene-related metal complexes in medicinal chemistry, serving as an accessible entry to bioorganometallic anticancer applications.
Key Papers Explained
'Organometallic Anticancer Compounds' by Gasser et al. (2010, 1571 citations) establishes the framework for non-platinum metal-based drugs, extending principles from 'Platinum Compounds: a New Class of Potent Antitumour Agents' by Rosenberg et al. (1969, 3890 citations), which introduced platinum efficacy. 'Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects' by Florea and Büsselberg (2011, 1720 citations) details resistance mechanisms that inform ferrocene design. 'Cisplatin: The first metal based anticancer drug' by Ghosh (2019, 1639 citations) contextualizes historical progress, linking to ferrocene's bioorganometallic evolution.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research continues on ferrocene derivatives' antiproliferative effects and chirality in cancer models, with no recent preprints or news in the last 6-12 months. Focus persists on synthesis and molecular modeling from established works like Gasser et al. (2010).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Cyclic polyethers and their complexes with metal salts | 1967 | Journal of the America... | 4.1K | ✕ |
| 2 | Platinum Compounds: a New Class of Potent Antitumour Agents | 1969 | Nature | 3.9K | ✕ |
| 3 | ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROL... | 1964 | Proceedings of the Nat... | 2.5K | ✕ |
| 4 | Character theory of finite groups | 1999 | Choice Reviews Online | 2.2K | ✓ |
| 5 | Cyclic polyethers and their complexes with metal salts | 1967 | Journal of the America... | 2.2K | ✕ |
| 6 | 6‐31G* basis set for third‐row atoms | 2001 | Journal of Computation... | 2.2K | ✕ |
| 7 | Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activi... | 2011 | Cancers | 1.7K | ✓ |
| 8 | Cisplatin: The first metal based anticancer drug | 2019 | Bioorganic Chemistry | 1.6K | ✕ |
| 9 | Organometallic Anticancer Compounds | 2010 | Journal of Medicinal C... | 1.6K | ✓ |
| 10 | Recent advances in poly(pyrazolyl)borate (scorpionate) chemistry | 1993 | Chemical Reviews | 1.5K | ✕ |
Frequently Asked Questions
What is the focus of ferrocene chemistry in medicinal applications?
Ferrocene chemistry centers on bioorganometallic derivatives for cancer research, including synthesis and antiproliferative effects. It explores their use as potential anticancer drugs and estrogen receptor modulators. Molecular modeling assesses their biochemical properties and biological activity.
How do organometallic compounds like ferrocene derivatives act against cancer?
Organometallic anticancer compounds, including ferrocene-based ones, induce tumor cell death via mechanisms like DNA interference, as in cisplatin analogs. 'Organometallic Anticancer Compounds' by Gasser et al. (2010) details their distinct profiles from platinum drugs. These compounds show promise in medicinal chemistry for overcoming resistance.
What role does chirality play in ferrocene applications?
Chirality organization in ferrocenes influences their biological activity in cancer research. Derivatives are studied for stereospecific interactions with biological targets. This aspect supports development of targeted antiproliferative agents.
Which papers establish organometallic compounds in anticancer research?
'Organometallic Anticancer Compounds' by Gasser et al. (2010) reviews ferrocene and related metal complexes with 1571 citations. It builds on platinum precedents like 'Platinum Compounds: a New Class of Potent Antitumour Agents' by Rosenberg et al. (1969, 3890 citations). These works ground ferrocene's medicinal potential.
What is the current scope of ferrocene research based on publication data?
The field includes 18,241 works on ferrocene chemistry and applications. It emphasizes bioorganometallic aspects in cancer and medicinal chemistry. Growth data over 5 years is not available.
Open Research Questions
- ? How can ferrocene derivatives be optimized to enhance selectivity for estrogen receptors in anticancer therapy?
- ? What molecular modeling approaches best predict the antiproliferative mechanisms of chiral ferrocene compounds?
- ? Which synthesis methods improve the biochemical stability of ferrocene-based drugs for clinical use?
- ? How do ferrocene complexes interact with DNA to produce effects distinct from cisplatin?
Recent Trends
The field maintains 18,241 works with no specified 5-year growth rate.
Citation leaders include 'Organometallic Anticancer Compounds' by Gasser et al. (2010, 1571 citations), emphasizing bioorganometallic anticancer applications.
No preprints or news from the last 6-12 months indicate steady focus on synthesis, chirality, and medicinal chemistry.
Research Ferrocene Chemistry and Applications with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Ferrocene Chemistry and Applications with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers